摘要
肺炎支原体肺炎是儿童常见的社区获得性肺炎类型之一,一般症状较轻且具有自限性。然而,少数病例会出现严重威胁生命的并发症,需要生命支持,这类病例被定义为危重症肺炎支原体肺炎。自2023年起,肺炎支原体在国内外广泛流行,危重症患儿占比呈上升趋势。当前,针对该类危重症患儿的研究较少,且多以病案报道为主,各病例临床表现多样,导致患儿临床特征尚不明确,难以切实有力地支持临床治疗。本综述聚焦于归纳危重症肺炎支原体肺炎患儿的临床特征,以期为临床医生实现早期识别与及时有效治疗提供思路。Mycoplasma pneumoniae pneumonia is one of the common types of community-acquired pneumonia in children, typically presents with mild symptoms and exhibits self-limiting properties. However, in a few cases, severe life-threatening complications occur, which require life support. Such cases are defined as fulminant Mycoplasma pneumoniae pneumonia. Since 2023, Mycoplasma pneumoniae has been widely prevalent at home and abroad, and the proportion of fulminant children has shown an upward trend. At present, there are limited studies on fulminant Mycoplasma pneumoniae pneumonia, and most of them are case reports. The clinical manifestations of each case vary, resulting in unclear clinical characteristics of the children, which makes it difficult to provide strong support for clinical treatment. This paper focuses on summarizing the clinical characteristics of children with fulminant Mycoplasma pneumoniae pneumonia, aiming to provide ideas for clinicians to achieve early identification and timely and effective treatment.
出处
《临床医学进展》
2025年第2期1428-1435,共8页
Advances in Clinical Medicine
